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ABSTRACT
Introduction Undisplaced femoral neck fractures 
(FNFs) are usually treated by internal fixation (IF) 
but two randomised controlled trials (RCTs) have 
demonstrated advantages of treatment with arthroplasty. 
The complication rate was lowered but there were no 
clinically improved patient- reported outcome measures 
(PROM), which could be due to underpowering or choice of 
selected PROM as the studies do appear to report a better 
functional outcome. We will conduct an RCT comparing IF 
with arthroplasties in patients aged over 65 years with an 
undisplaced FNF.
Methods and analysis All hospitals in Denmark treating 
patients with hip fracture can provide patients for this 
study; therefore, the study can be considered a national 
RCT. Patients over 65 years old with an undisplaced 
FNF will be screened for eligibility and patients will only 
be excluded if they are unable to understand the study 
information (due to dementia or language), if they have a 
posterior tilt >20°, a pathological fracture or they cannot 
walk. Participants will be electronically randomised (in 
alternating blocks of 4 or 6) into either IF or arthroplasty. 
Postoperative care will follow the department standards.
Primary and secondary outcomes and measuring points 
have been established in collaboration with patients 
with hip fracture by focus group interviews. The primary 
outcome measure is the New Mobility Score assessed 
after 1 year. Secondary outcomes are the Oxford Hip Score, 
EuroQol 5 domain (EQ- 5D- 5L), degree of posterior tilt, pain 
Verbal Rating Scale, reoperation and mortality.
Ethics and dissemination The study is approved by the 
Danish Data Protection Agency (19/7429) and the scientific 
ethics committee (S-20180036). All participants will sign 
an informed consent before entering the trial. Because this 
is a national trial, all relevant healthcare professionals in 
Denmark will automatically receive the trial results that 
will be published in international peer- reviewed journals.
Trial registration number  ClinicalTrials. gov Registry 
(NCT04075461).
INTRODUCTION
Arthroplasty for a displaced femoral neck frac-
ture (FNF) in the elderly is recommended by 
most guidelines.1 2 For the undisplaced FNF, 
internal fixation is the only recommendation; 
however, it is questioned whether there is an 
alternative treatment.
Recently, two randomised controlled trials 
(RCTs) comparing internal fixation with 
hemiarthroplasty have been published.3 4 
Both RCTs demonstrated a lower reoperation 
frequency in the hemiarthroplasty group 
(5%) compared with internal fixation (20%–
21%). Lu et al3 found a slightly higher Harris 
Hip Score after 6 months and 1 year in favour 
of hemiarthroplasty but not thereafter. Dola-
towski et al4 found a faster mobility (Timed- 
Up- And- Go) but no difference in the Harris 
Hip Score. These studies did not show a clin-
ical difference in Harris Hip Scores, but this 
measure may not be the best primary outcome 
measure due to the ceiling effect and lack of 
validation for patients with hip fracture.5
Mobilisation after hip fracture is perhaps 
the most important factor for mortality after 
surgery6 and surgery should, therefore, aim 
for fast mobilisation. Arthroplasty may be a 
good choice, as it may yield faster recovery 
than internal fixation.7 A systematic review8 
in 2008 of mobility instruments for older 
patients showed that no existing instrument 
had the properties required to measure and 
monitor the mobility of older acute medical 
Strengths and limitations of this study
 ► National randomised controlled trial (RCT) on un-
displaced femoral neck fracture comparing internal 
fixation with arthroplasty.
 ► It is a pragmatic RCT and each hospital can use their 
preferred implants.
 ► Primary outcome is an easily understood functional 
score, the New Mobility Score.
 ► Participants are only included if they are able to walk 
outside with no help from other individuals.
 ► The participants and assessors are blinded concern-
ing implant.
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patients accurately. The New Mobility Score (NMS) devel-
oped by Parker may predict mortality,9 and Kristensen 
et al have since shown that it can also predict function 
better than Timed- Up- and- Go. NMS is easy to use and 
has a very high inter- tester reliability.10 11 Pedersen and 
Lauritsen12 also demonstrated good correlation of NMS 
and gait function prediction with the same properties 
as Barthel-20 and Barthel-100 but with a lower ceiling 
frequency of 4 months postoperatively.
Even though the evidence is limited from the two 
RCTs,3 4 one could argue for implementing arthroplasty 
for undisplaced FNF since there are fewer reoperations 
and perhaps a faster mobilisation. However, a cohort study 
has demonstrated a higher mortality percentage when 
using hemiarthroplasty compared with internal fixation.13 
This study does contain selection bias and confounding 
problems, as there are in general with cohort studies, 
which makes the resulting evidence limited for everyday 
clinical use. Therefore, we should conduct larger RCTs as 
hip fracture RCTs, in general, are small and underpow-
ered.14 In addition, external validity is often a problem 
in traditional RCTs, because an inclusion rate as little as 
7% was seen in the FAITH Study15 thereby questioning 
whether hip fracture trials exclude too many patients.16 
A pragmatic RCT design includes a larger proportion of 
the eligible patients due to fewer exclusion criteria and 
could, therefore, be a better choice to test an interven-
tion in everyday clinical setting.17
The aim of this trial is to compare functional outcomes 
of arthroplasty with internal fixation for patients over 65 
years old with an undisplaced FNF. The study is designed 
as a national single- blinded pragmatic 1:1 RCT. The 
hypothesis states that arthroplasty is superior to internal 
fixation using the NMS as the primary outcome.
METHODS: PARTICIPANTS, INTERVENTIONS AND OUTCOMES
Study setting
The Danish National Health Service provides tax- 
supported free healthcare and general hospital care 
for all Danish citizens.18 All patients with hip fracture 
are treated at public hospitals in Denmark as no private 
hospitals in Denmark have any acute fracture treatment. 
Twenty public hospitals in Denmark treat patients with 
hip fracture and all participate in this study, making this 
trial a national RCT.
The trial started 1st of February 2020 but has been 
paused due to COVID-19. The sites will start recruitment 
at different time points from 1st of July to 1st of October.
Trial design
The study is designed as a national pragmatic RCT, 
including all patients with an undisplaced FNF and an 
NMS of 5 and above. The current standard treatment in 
Denmark is internal fixation, and patients are randomised 
to either arthroplasty or internal fixation. The steering 
group has assessed the pragmatic attitude of the design 
and the study reaches five points in seven of the nine 
domains (figure 1).17 Reporting will be performed 
according to the extension of the Consolidated Standards 
of Reporting Trials statements for a pragmatic RCT,19 
and this protocol is reported according to the Standard 
Protocol Items: Recommendations for Interventional 
Trials statement.20
Eligibility criteria
All patients with an undisplaced FNF classified as either 
Garden type I or II21 are evaluated. The patients are 
included if:
 ► Age ≥65 years.
 ► Undisplaced FNF.
 ► Posterior tilt22 <20°.
 ► NMS=5 and above, indicating an ability to walk prior 
to the fracture.
 ► Cognitive state intact to achieve informed consent.
Patients are excluded if:
 ► The fracture is pathological.
 ► The patient does not speak or understand Danish 
language.
To ensure correct fracture classification, an adjudica-
tion committee will evaluate all included X- ray images.
Interventions
Participants are randomised to either arthroplasty or 
internal fixation. Because the treatment options at each 
hospital may be very different, arthroplasty can include 
total hip arthroplasty (cemented, uncemented, hybrid, 
dual- mobility cup) or hemiarthroplasty (cemented, unce-
mented) using the institution’s regular surgical approach 
(18 hospitals only use the posterior approach). Internal 
fixation can include either two or three screws/pins or 
a sliding hip screw. After discharge, all patients will be 
referred to standard rehabilitation in the municipalities 
and will be seen in their own home or at the orthopaedic 
Figure 1 Assessment of pragmatic design using the 
PRagmatic Explanatory Continuum Indicator Summary-2 
wheel.
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department for outcome assessment after 3, 6 and 12 
months. X- ray will be performed postoperatively within 
discharge and after 12 months.
Outcomes
Primary and secondary outcomes and measuring points 
have been established in collaboration with a focus group 
interview with patients with hip fracture. The primary 
outcome measure is NMS assessed after 12 months. NMS 
will also be assessed at baseline, 3 and 6 months.
Secondary outcome measures evaluated at the same 
time points are the Oxford Hip Score, EuroQol 5 domain, 
pain Verbal Rating Scale,23 reoperation (any surgery 
related to the implants including closed reduction) 
and mortality. Explorative outcome measures are the 
de Morton Mobility Index,7 24 Barthel-20,25 Cumulated 
Ambulation Score,26 X- ray measurements and activity 
tracking.
Information will be retrieved from patient interview 
and healthcare records on the following:
 ► Demographics: age, sex, residency, prefracture 
mobility.
 ► Comorbidity: American Society of Anaesthesiologists 
Classification, diseases, medication, smoking, alcohol.
 ► Admission: time of admission, duration of hospital 
stay, concurrent infection, fracture time.
 ► Surgery: start and end of surgery, type of implant, 
surgical experience, blood loss.
 ► X- ray: quality of implant positioning.27–29
 ► Biochemistry: haemoglobin, leucocytes, C reactive 
protein, estimated glomerular filtration rate, interna-
tional normalised ratio, blood transfusions.
 ► Complications: postoperative medical complications 
(all possible such as heart, lung, abdominal, brain, 
electrolytes, fall and infection), readmissions.
A timeframe for the collection of data is provided in 
table 1. Healthcare record information is collected for 
research purposes only to compare patient groups and 
treatment.
Sample size calculation
A minimal clinically important difference in NMS of 1 
point was taken from Kristensen’s thesis30 and a 1- year 
average of 6.4 points with an SD of 2.2 from Steihaug et 
al.31 The sample size was calculated using a 1- point differ-
ence, an SD of 2.2, allowing a 5% probability of type 1 
error and applying 95% statistical power. Consequently, 
127 patients are required in each group and to allow for 
loss during follow- up due to mortality and other causes 
(30%). Therefore, a total of 330 patients are required for 
the study.
Recruitment
All patients are recruited in the emergency department 
when diagnosed with an undisplaced FNF. The admit-
ting doctor or a senior consultant will inform the patient 
about the trial while the patient is in the emergency 
department. The information will be given verbally as 
well as by written participant information in an undis-
turbed room in the emergency department. If no next 
of kin are present, they will be invited to attend by phone 
if requested by the participant. Otherwise, an impartial 
assessor can be assigned. Because surgery is required to 
take place as quickly as possible due to a higher risk of 
Table 1 Timeframe for collection of data
Admission 2 weeks 6 weeks 3 months 6 months 12 months At event
Demographics X           
Comorbidity X           
Admission X           
Surgery X           
Blood X           
X- ray X       X
NMS X   X X X
Pain VRS X X X X X X
OHS X   X X X
EQ- 5D- 5L X   X X X
DEMMI X   X X X
Barthel-20 X   X X X
CAS X X X     
Reoperation           X
Complications           X
Mortality           X
CAS, Cumulated Ambulation Score; DEMMI, de Morton Mobility Index; EQ- 5D- 5L, EuroQol 5 domain; NMS, New Mobility Score; OHS, 
Oxford Hip Score; VRS, Verbal Rating Scale.
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mortality when delaying surgery, a reflection time of only 
2 hours has been approved. Retrieval of informed consent 
will take place at either the emergency department or the 
ward.
Patient and public involvement
We conducted a focus group interview with patients 
with hip fracture with internal fixation or arthroplasty at 
Hospital Lillebaelt, which involved six patients (and their 
relatives) aged 70–94 years who had received surgery 
6–12 months prior to the interview. They were inter-
viewed using a structured interview guide. The interview 
consisted of open questions regarding their hip fracture 
experience, their subsequent consequences/challenges 
and what was important for them to regain. Further ques-
tions relating specifically to the study were also included. 
The questionnaires were easily understood, and all 
found them relevant. All questions were answered, and 
the most important outcome reported was for all func-
tional outcomes, especially the ability to walk properly. 
Pain was also an important consideration, especially for 
the internal fixation group. All participants felt that the 
most important time for measuring outcomes would be 
after 1 year, but measuring during the first year was also 
important.
The study protocol was presented to the Patient and 
Relatives Council at Hospital Lillebaelt afterwards, with 
no additional remarks.
METHODS: ASSIGNMENT OF INTERVENTIONS
Allocation
Treatment is divided into two strands and patients eligible 
for inclusion can be enrolled if they provide informed 
consent. Patients are entered into an electronic database 
(REDCap) and thereafter randomised using random 
blocks of n=4 or n=6 stratified by hospital. When the 
patient is called to the theatre, the surgeon will determine 
which implant to use by consulting REDCap; accordingly, 
REDCap will be used to create two groups representing 
each implant type.
Blinding
The surgeon and theatre staff cannot be blinded, but a 
standard phrase for the surgery will be used to blind the 
patient. According to standards of care and journal publi-
cation requirements, the coordinating staff can reveal 
the true surgery in case of severe pain or complications; 
otherwise, patients will not know until the end of the trial. 
The assessors will assess patients in their own home and 
will be blinded according to the type of surgery.
Methods
Data collection, management and analysis.
Data collection methods
Data will be collected by project staff. Baseline data will 
be collected during admission, and all data concerning 
patient- reported outcomes and physical assessment are 
collected by a physiotherapist in the patient’s own home 
or in the outpatient clinic depending on the participant’s 
wish.
Data management
Data will be entered directly into the project’s REDCap 
database when assessing or interviewing the participants.
Statistical methods
All variables are described according to their distribu-
tion. Groups will be compared by linear mixed models 
for numerical data and logistic mixed models for dichot-
omous data including a random effect for hospital. Both 
unadjusted analyses as well as analyses adjusting for demo-
graphic variables, comorbidity, mobility, type of implant, 
reoperation and mortality will be carried out. Distribu-
tional assumptions on residuals and random effects will 
be investigated by quantile–quantile plots, and in case of 
deviations from distributional assumptions bootstrapping 
with 1000 replicates will be used to estimate CIs and p 
values. All group comparisons will be carried out both 
as intention- to- treat analysis and per- protocol analysis. 
Mortality will be analysed by Cox- regression with base-
line hazards stratified by hospital. As sensitivity analyses 
competing risk regression models will be applied.
Methods: monitoring
Data monitoring
After data retrieval from the first 70 patients, an interim 
analysis will be performed regarding mortality and func-
tion. If there is a difference of 10% in 30 days mortality, 
a consensus decision by steering group whether the trial 
should be stopped will be conducted. Likewise, if the NMS 
score shows 2 points or more difference after 3 months, 
all authors are asked whether the trial should be stopped. 
This is because the required sample size would then be 
66 patients.
Potential harms
Any unforeseen complications that occur during the trial 
will be registered in the project’s REDCap database.
Auditing
An adjudication committee will audit all X- ray images.
ETHICS AND DISSEMINATION
Research ethics approval
The study is approved by the Danish Data Protection 
Agency (19/7429) and the Scientific Ethics Committee 
with the project ID number S-20180036. It was first 
approved on the 15th October 2018 and a revision was 
approved 8th October 2019.
Consent or assent
The orthopaedic surgeon on call is responsible for 
including patients. The patients have to give a written 
consent (online supplemental appendix 1) before 
entering the trial.
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Confidentiality
Project data are securely stored in the project’s REDCap 
database, and when the trial is completed, data are stored 
in the Danish Data Archive.
Ancillary and post-trial care
Any patients who experience any harm due to this trial 
will have the same care as all other patients in Denmark 
through the independent Danish Patient Compensation 
Association.
Dissemination policy
This is a national trial and all 20 hospitals providing hip 
fracture care are included. All relevant healthcare profes-
sionals involved in hip fracture treatment in Denmark 
will, therefore, automatically be informed of the trial 
results. The results will also be published in international 
peer- reviewed journals.
Perspective
By conducting a national pragmatic RCT, external validity 
will potentially be high. A general problem with trials is 
the lack of clinical impact afterwards as one paper has 
shown that it takes an average of 17 years for new findings 
to reach clinical practice. As this is a nationwide study, 
the impact of the results is expected to be immediate and 
high.
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